Federal jury rules against Prevagen maker in deceptive marketing case over unsubstantiated memory claims

Summary

A federal jury has handed down a verdict in the deceptive marketing case against Prevagen's maker, Quincy Bioscience. The case, brought by the New York attorney general and the FTC, challenged unsubstantiated claims that the supplement improves memory. The court ordered Quincy to remove all challenged claims from its marketing, including memory-improvement claims. Quincy has indicated it will appeal but has already removed the claims. The case originated nine years ago when TINA.org alerted regulators to the supplement's unsubstantiated health claims.

Source

bskyFederal jury rules against Prevagen maker in deceptive marketing case over unsubstantiated memory claimstruthinadvertising.org